BridgeBio Pharma Inc
(NAS:BBIO)
$
29.08
-0.37 (-1.26%)
Market Cap: 5.50 Bil
Enterprise Value: 6.97 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 41/100 
BridgeBio Pharma Inc at Piper Jaffray Healthcare Conference Transcript
Dec 03, 2019 / 05:30PM GMT
Release Date Price:
$30.56
(-1.86%)
Tyler Martin Van Buren
Piper Sandler & Co., Research Division - Principal & Senior Biotech Analyst
All right. Great. Thanks again to everyone for coming to Piper Jaffray 31st Annual Healthcare Conference. Welcome. My name is Tyler Van Buren, I'm a biotech analyst here at Piper Jaffray. This next session, we're very pleased to have Neil Kumar, the Founder and CEO of BridgeBio and Eidos here. There's a lot to discuss. So I'll just go ahead and get straight into it.
Neil Kumar
BridgeBio Pharma, Inc. - Co-Founder, CEO & Director
I apologize in advance. I'm losing my voice, a little sick. Hopefully everyone can hear me.
Questions & Answers
Tyler Martin Van Buren;Neil Kumar
Piper Sandler & Co., Research Division - Principal & Senior Biotech Analyst;BridgeBio Pharma, Inc. - Co-Founder, CEO & Director
Yes. And perhaps you could just start by providing a brief overview of the company and the concept behind it and why you decided to go public earlier.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers